DOCK3 and glaucoma: Additionally, Dock3 has been shown to mitigate oxidative damage through suppression of the apoptosis signal-regulating kinase 1 (ASK1) pathway, which is activated in response to cellular stress and is implicated in RGC loss in glaucoma models [116,117].